Sustained endosomal release of a neurokinin-1 receptor antagonist from nanostars provides long-lasting relief of chronic pain

纳米星持续内体释放神经激肽-1受体拮抗剂,可长期缓解慢性疼痛。

阅读:9
作者:Rocco Latorre ,Paulina D Ramírez-Garcia ,Alan Hegron ,James L Grace ,Jeffri S Retamal ,Priyank Shenoy ,Mai Tran ,Luigi Aurelio ,Bernard Flynn ,Daniel P Poole ,Rafael Klein-Cloud ,Dane D Jensen ,Thomas P Davis ,Brian L Schmidt ,John F Quinn ,Michael R Whittaker ,Nicholas A Veldhuis ,Nigel W Bunnett

Abstract

Soft polymer nanoparticles designed to disassemble and release an antagonist of the neurokinin 1 receptor (NK1R) in endosomes provide efficacious yet transient relief from chronic pain. These micellar nanoparticles are unstable and rapidly release cargo, which may limit the duration of analgesia. We examined the efficacy of stable star polymer nanostars containing the NK1R antagonist aprepitant-amine for the treatment of chronic pain in mice. Nanostars continually released cargo for 24 h, trafficked through the endosomal system, and disrupted NK1R endosomal signaling. After intrathecal injection, nanostars accumulated in endosomes of spinal neurons. Nanostar-aprepitant reversed mechanical, thermal and cold allodynia and normalized nociceptive behavior more efficaciously than free aprepitant in preclinical models of neuropathic and inflammatory pain. Analgesia was maintained for >10 h. The sustained endosomal delivery of antagonists from slow-release nanostars provides effective and long-lasting reversal of chronic pain. Keywords: Endosomes; Nociception; Pain; Receptors; Signal transduction.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。